Lack of interferon‐beta bioactivity is associated with the occurrence of relapses in multiple sclerosis

Abstract

Our results suggest that a lack of IFNbeta bioactivity is associated with the occurrence of relapses and therefore can be useful as a biomarker for unresponsiveness to IFNbeta.